Why Women Face Higher Insomnia Risk at Every Stage of Life

Why Are Women More Likely to Develop Insomnia Than Men?

Research consistently shows that women are significantly more likely to experience insomnia than men, with the disparity emerging after puberty and widening with age. According to data reviewed by the American Academy of Sleep Medicine, women have approximately 40 to 50 percent greater odds of developing insomnia compared to men. This gap is largely attributed to the influence of reproductive hormones — estrogen and progesterone — on sleep-regulating neurotransmitter systems, including GABA and serotonin pathways.

The vulnerability is not static. Women face distinct periods of elevated risk tied to hormonal transitions: the premenstrual phase of each cycle, pregnancy and the postpartum period, and the menopausal transition. During each of these windows, shifting hormone levels can alter circadian rhythm regulation, core body temperature, and arousal thresholds during sleep. A Frontiers in Neuroscience review examining insomnia across the female lifespan emphasizes that these are not isolated events but a recurring pattern that requires longitudinal, sex-specific clinical attention.

How Does Menopause Affect Sleep Quality?

The menopausal transition represents the period of greatest insomnia risk for women. Studies published in the journal Sleep indicate that up to 60 percent of perimenopausal and postmenopausal women report clinically significant sleep disturbances. Vasomotor symptoms — hot flashes and night sweats — are a primary driver, causing frequent awakenings and reduced time in restorative slow-wave sleep. However, even women without vasomotor symptoms experience elevated insomnia rates during this transition, suggesting that hormonal decline itself directly impacts sleep neurobiology.

Progesterone, which has sedative properties through its action on GABA-A receptors, declines sharply during perimenopause. This decline is associated with increased sleep onset latency and more fragmented sleep. The North American Menopause Society notes that sleep complaints are among the most common reasons women seek care during midlife. Cognitive behavioral therapy for insomnia (CBT-I) remains the first-line treatment recommended by major guidelines, though hormone replacement therapy may offer additional benefit for sleep disturbances linked directly to vasomotor symptoms.

What Can Women Do to Improve Sleep Across Their Lifespan?

Major sleep medicine organizations, including the American College of Physicians, recommend CBT-I as the first-line treatment for chronic insomnia in adults, regardless of sex. CBT-I addresses the cognitive and behavioral patterns that perpetuate poor sleep — such as excessive time in bed, anxiety about sleep, and irregular schedules — and has been shown in meta-analyses to produce durable improvements without the side effects associated with long-term use of sleep medications.

For women experiencing sleep disruption tied to specific hormonal transitions, a multidisciplinary approach is increasingly recommended. During pregnancy and postpartum, targeted sleep hygiene strategies and screening for mood disorders can help identify women at risk. During perimenopause, clinicians are advised to evaluate whether vasomotor symptoms are contributing to insomnia before prescribing hypnotic medications. Regular physical activity, consistent sleep-wake schedules, and limiting evening light exposure remain foundational recommendations supported by the National Sleep Foundation. Experts stress that normalizing the conversation around women's sleep health is essential — sleep disruption at these life stages is common but not inevitable, and effective treatments are available.